Vaccine Hesitancy: In the Age of the COVID-19 Pandemic
Asian Journal of Research in Infectious Diseases,
Vaccines are one of the most significant innovations of modern science. Worldwide, millions of lives are saved each year by the vaccine. Vaccine hesitancy, which represents the refusal to receive vaccines when vaccination services are available and reachable, is a major obstacle to global health. While vaccine hesitancy has been present for many years, its damaging effects are likely to be more evident during the COVID-19 pandemic than ever before. This study aimed to find out common causes of vaccine hesitancy, assess COVID-19 vaccination acceptance rates worldwide, and present the approaches by which vaccine hesitancy rate can be reduced. This study revealed though vaccine hesitancy is a worldwide phenomenon, the causes differ from country to country or reign. More studies are needed to address COVID-19 vaccine hesitancy, especially in the Middle and South America, the Middle East and North Africa, Central Asia, Sub-Saharan Africa, Eastern Europe. The leading causes of COVID-19 vaccine hesitancy are found lack of confidence towards the government or pharmaceutical companies, less concern about the outcome of SARS-CoV-2 infection, and shortage of supply of different types of COVID-19 vaccines. Healthcare personnel and social media play an essential role in addressing vaccine hesitancy. Convincing the general population about the safety and effectiveness of COVID-19 vaccines, the consequence of being unvaccinated, and the delivery of free vaccines in an easily accessible way can reduce vaccine hesitancy rate.
- Vaccine, social media
- information science
- immunization program
- national vaccination campaign
How to Cite
Fridman A, Gershon R, Gneezy A. COVID-19 and vaccine hesitancy: A longitudinal study. PLOS ONE. 2021;16(4):e0250123.
Anderson RM, Vegvari C, Truscott J, Collyer BS. Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination. The Lancet. 2020;396(10263):1614–6.
Holder J. Tracking Coronavirus Vaccinations Around the World. The New York Times [Internet]; 2021.
COVID-19 [Internet]. [cited 2021 Sep 23].
Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020;26:100495.
global-attitudes-on-a-covid-19-vaccine-december-2020-report.pdf [Internet]. [cited 2021 Sep 12].
Xia Y, Zhong L, Tan J, Zhang Z, Lyu J, Chen Y, et al. How to understand "herd immunity" in COVID-19 pandemic. Front Cell Dev Biol. 2020;8:991.
MacDonald NE. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015;33(34):4161–4.
Ten health issues WHO will tackle this year [Internet]. [cited 2021 Sep 12].
Troiano G, Nardi A. Vaccine hesitancy in the era of COVID-19. Public Health. 2021;194:245–51.
Missouri Society of Health-System Pharmacists - Combatting Vaccine Hesitancy [Internet]. [cited 2021 Sep 14].
1_Report_WORKING_GROUP_vaccine_hesitancy_final.pdf [Internet]. [cited 2021 Sep 15].
Chevallier C, Hacquin A-S, Mercier H. COVID-19 Vaccine Hesitancy: Shortening the Last Mile. Trends Cogn Sci. 2021;25(5):331–3.
Wagner AL, Masters NB, Domek GJ, Mathew JL, Sun X, Asturias EJ, et al. Comparisons of vaccine hesitancy across five low-and middle-income countries. Vaccines. 2019;7(4):155.
wellcome-global-monitor-2018.pdf [Internet]. [cited 2021 Sep 13].
Larson HJ, De Figueiredo A, Xiahong Z, Schulz WS, Verger P, Johnston IG, et al. The state of vaccine confidence 2016: global insights through a 67-country survey. E Bio Medicine. 2016;12:295–301.
Brewer NT, Chapman GB, Rothman AJ, Leask J, Kempe A. Increasing vaccination: putting psychological science into action. Psychol Sci Public Interest. 2017;18(3): 149–207.
Abedin M, Islam MA, Rahman FN, Reza HM, Hossain MZ, Hossain MA, et al. Willingness to vaccinate against COVID-19 among Bangladeshi adults: Understanding the strategies to optimize vaccination coverage. PLOS ONE. 2021;16(4): e0250495.
Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, et al. acceptance of a COVID-19 vaccine in Southeast Asia: a cross-sectional study in Indonesia. Front Public Health. 2020;8.
Wang J, Jing R, Lai X, Zhang H, Lyu Y, Knoll MD, et al. Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines. 2020;8 (3):482.
Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27 (2):225–8.
Rhodes A, Hoq M, Measey M-A, Danchin M. Intention to vaccinate against COVID-19 in Australia. Lancet Infect Dis. 2021;21(5):e110.
Sarasty O, Carpio CE, Hudson D, Guerrero-Ochoa PA, Borja I. The demand for a COVID-19 vaccine in Ecuador. Vaccine. 2020;38(51):8090–8.
La Vecchia C, Negri E, Alicandro G, Scarpino V. Attitudes towards influenza vaccine and a potential COVID-19 vaccine in Italy and differences across occupational groups, September 2020. Med Lav. 2020;111(6):445.
Grech V, Gauci C, Agius S. Vaccine hesitancy among Maltese healthcare workers toward influenza and novel COVID-19 vaccination. Early Hum Dev;2020.
Sallam M, Dababseh D, Eid H, Al-Mahzoum K, Al-Haidar A, Taim D, et al. High rates of COVID-19 vaccine hesitancy and its association with conspiracy beliefs: A study in Jordan and Kuwait among other Arab countries. Vaccines. 2021;9(1): 42.
Salali GD, Uysal MS. COVID-19 vaccine hesitancy is associated with beliefs on the origin of the novel coronavirus in the UK and Turkey. Psychol Med. 2020;1–3.
Al-Mohaithef M, Padhi BK. Determinants of COVID-19 vaccine acceptance in Saudi Arabia: a web-based national survey. J Multidiscip Healthc. 2020;13:1657.
Dror AA, Eisenbach N, Taiber S, Morozov NG, Mizrachi M, Zigron A, et al. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020;35(8):775–9.
NextDecadeOfVaccines_Single_NoBleed.pdf [Internet]. [cited 2021 Sep 14].
Sallam M. COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates. Vaccines. 2021;9(2):160.
Aw J, Seng JJB, Seah SSY, Low LL. COVID-19 Vaccine Hesitancy—A Scoping Review of Literature in High-Income Countries. Vaccines. 2021;9(8):900.
Shaw J, Stewart T, Anderson KB, Hanley S, Thomas SJ, Salmon DA, et al. Assessment of US health care personnel (HCP) attitudes towards COVID-19 vaccination in an extensive university health care system. Clin Infect Dis Off Publ Infect Dis Soc Am;2021.
Gharpure R, Guo A, Bishnoi CK, Patel U, Gifford D, Tippins A, et al. Early COVID-19 first-dose vaccination coverage among residents and staff members of skilled nursing facilities participating in the pharmacy partnership for long-term care program—United States, December 2020–January 2021. Morb Mortal Wkly Rep. 2021;70(5):178.
Barello S, Nania T, Dellafiore F, Graffigna G, Caruso R.' Vaccine hesitancy'among university students in Italy during the COVID-19 pandemic. Eur J Epidemiol. 2020;35(8):781–3.
Larson H. Vaccine hesitancy among healthcare workers and their patients in Europe: A Qualitative Study. ECDC; 2015.
Kwok KO, Li K-K, WEI WI, Tang A, Wong SYS, Lee SS. Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: A survey. Int J Nurs Stud. 2021;114: 103854.
Nzaji MK, Ngombe LK, Mwamba GN, Ndala DBB, Miema JM, Lungoyo CL, et al. Acceptability of vaccination against COVID-19 among healthcare workers in the Democratic Republic of the Congo. Pragmatic Obs Res. 2020;11:103.
Piedrahita-Valdés H, Piedrahita-Castillo D, Bermejo-Higuera J, Guillem-Saiz P, Bermejo-Higuera JR, Guillem-Saiz J, et al. Vaccine Hesitancy on Social Media: Sentiment Analysis from June 2011 to April 2019. Vaccines. 2021;9(1):28.
Azizi FSM, Kew Y, Moy FM. Vaccine hesitancy among parents in a multi-ethnic country, Malaysia. Vaccine. 2017;35(22):2955–61.
Deiner MS, Fathy C, Kim J, Niemeyer K, Ramirez D, Ackley SF, et al. Facebook and Twitter vaccine sentiment in response to measles outbreaks. Health Informatics J. 2019;25(3):1116–32.
Chanel O, Luchini S, Massoni S, Vergnaud J-C. Impact of information on intentions to vaccinate in a potential epidemic: Swine-origin Influenza A (H1N1). Soc Sci Med. 2011;72(2):142–8.
Altay S, Hacquin A-S, Chevallier C, Mercier H. Information Delivered by a Chatbot Has a Positive Impact on COVID-19 Vaccines Attitudes and Intentions [Internet]. Psy Ar Xiv; 2021 [cited 2021 Sep 22].
Chapman GB, Li M, Colby H, Yoon H. Opting In vs Opting Out of Influenza Vaccination. JAMA. 2010;304(1):43– 4.
Vann JCJ, Jacobson RM, Coyne‐Beasley T, Asafu‐Adjei JK, Szilagyi PG. Patient reminder and recall interventions to improve immunization rates. Cochrane Database Syst Rev. 2018;(1).
Zhou Q, Gao Y, Wang X, Liu R, Du P, Wang X, et al. Nosocomial infections among patients with COVID-19, SARS and MERS: a rapid review and meta-analysis. Ann Transl Med. 2020;8(10).
Riphagen-Dalhuisen J, Burgerhof J, Frijstein G, Van Der Geest-Blankert A, Danhof-Pont M, De Jager H, et al. Hospital-based cluster randomised controlled trial to assess effects of a multi-faceted programme on influenza vaccine coverage among hospital healthcare workers and nosocomial influenza in the Netherlands, 2009 to 2011. Eurosurveillance. 2013;18(26):20512.
Abstract View: 192 times
PDF Download: 45 times